Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day

The Shared Goals: Navigating Alzheimer’s Agitation survey found that agitation associated with Alzheimer’s disease is frequently not recognized until it has significantly disrupted daily life. The findings underscore a potential gap in earlier identification and management of behavioral symptoms, but do not provide financial, clinical-trial, or company-specific data.